Addition of steroids drugs to MS treatment can reduce disease activity  When steroid drugs are added to multiple sclerosis (MS) treatment, the risk of disease activity gets reduced to a considerable extent as per a study presented as a part of the Late-breaking Science Program at the American Academy of Neurology’s 61st Annual Meeting in Seattle.

It was remarked by study author Mads Ravnborg, MD, of the Danish Multiple Sclerosis Research Center at Copenhagen University Hospital in Denmark, that results of this study highlight the fact that the two drugs tend to bring synergy in a combination and provide an improved beneficial effect on the disease activity as against use of the MS drug in isolation.

 


Comments

comments